ABOUT
TEAM
STRATEGY
PORTFOLIO
NEWS
More
BioStar Capital invests in and nurtures transformative medical technologies. We have consistently produced life-changing outcomes for patients and rewarding returns for investors.
Transcatheter renal denervation for hypertension.
Passive implant for treating pulmonary hypertension.
Pulsed field ablation (PFA) for ventricular tachycardia (VT).
Robotically manufactured polymer heart valve.
Robotic microsurgery using NanoWrist instruments.
Endovascular therapy for stabilizing abdominal aortic aneurysms (AAA).
Handheld tear stimulation device for dry eye disease.
Bioresorbable polymer technologies for vascular applications.
Simple, percutaneous tricuspid valve repair without surgery.